JNJ as of Oct 31 · 19:14 ET
JNJNYSEPharmaceutical Preparations

Johnson & Johnson · Brief

Next report

81 days

Jan 20 · before openest.Q4 FY26

Expected move

No implied move.

Implied vs realized

8 reportsHistory
2 of 8≥ implied
avg implied
±2.6%
avg realized
±2.3%
Jan 22 '25±2.1%▼−1.94%×0.94
Apr 15 '25±2.2%▼−0.48%×0.21
Jul 16 '25±2.1%▲+6.19%×2.89
Oct 14 '25±2.8%▼−0.03%×0.01
Jan 21 '26±2.8%▼−0.09%×0.03
Q1 FY26±3.0%▲+0.90%×0.30
Q2 FY26±2.9%▼−2.69%×0.94
Q3 FY26±3.1%▼−5.73%×1.86
quarterimplied−10%0+10%realized×
Q3 FY26±3.1%▼−5.73%×1.86
Q2 FY26±2.9%▼−2.69%×0.94
Q1 FY26±3.0%▲+0.90%×0.30
Jan '26±2.8%▼−0.09%×0.03
Oct '25±2.8%▼−0.03%×0.01
Jul '25±2.1%▲+6.19%×2.89
2 older reports
Apr '25±2.2%▼−0.48%×0.21
Jan '25±2.1%▼−1.94%×0.94
Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Bull & bear

Jan 20 report · est.

Bull2 of 4

3customers disclosing JNJ as a supplierSEC filings
4,698managers reporting a position in the latest quarterly filings13F · Jun 30 '26

Bear2 of 3

10 of 22of the largest reporting managers cut their stake in the latest quarter13F · Jun 30 '26
6 of 8recent reports where the move came in under the options implied rangeEarnings history
AI captions · Oct 19 '26once per report · top 2 per case

Linked exposure

JNJ report session

No linked exposure.

Latest changes

30 daysAll changes
Oct 5unusualUnusual volume: ×2.12 RVOL at 10:30 ET.Source

Your note

privateThesis 0 · Decisions 0 · Observations 0

No thesis.